Home
Conditions
Orthomyxoviridae Infections

Clinical trial condition

Orthomyxoviridae Infections

Explore clinical trials studying Orthomyxoviridae Infections. Study availability and eligibility vary by location and protocol.

1,810 public trials 85 recruiting studies

Refine in advanced search Browse all conditions

Orthomyxoviridae Infections trial results

Completed

Influenza A H3N2 Human Challenge Study in Healthy Adult Volunteers

NCT02594189

Conditions: Determine Minimally to Moderately Infective Dose (MMID) of Influenza A H3N2, Infections, Influenza, Human, +5 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Study of S-033188 (Baloxavir Marboxil) Compared With Placebo or Oseltamivir in Patients With Influenza at High Risk of Influenza Complications

NCT02949011

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: Not specified

View Trial Details

Completed

Study of a Parenterally Administered H5N1 Influenza Vaccine in Healthy Adults

NCT00868218

Conditions: Healthy, Infections, Influenza, +6 more
Locations: Haukeland Univeristy Hospital Bergen, Norway

View Trial Details

Completed

Study to Evaluate the Immunogenicity & Safety of an Investigational Influenza Vaccine (H1N1) in Adults

NCT00968539

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: GSK Investigational Site Ghent, Belgium

View Trial Details

Completed

Evaluation of a Recombinant Quadrivalent Influenza Vaccine Versus a Marketed Quadrivalent Inactivated Influenza Vaccine in Children 3 to 17.

NCT03460743

Conditions: Infections, Influenza, Human, Orthomyxoviridae Infections, +4 more
Locations: Clinical Research Institute Saltillo Saltillo, Coahuila, Mexico

Centro de Investigacion Clinica del Pacifico Acapulco de Juárez, Guerrero, Mexico

AMIC Pachuca Pachuca, Hidalgo, Mexico

Instituto Jalisciencie de Metabolismo Guadalajara, Jalisco, Mexico

View Trial Details

Completed

Study of GSK Biologicals' Influenza Vaccine Arepanrix™ in Japanese Adults 65 Years of Age or Older

NCT01114620

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: GSK Investigational Site Fukuoka, Japan

View Trial Details

Completed

Study to Assess Efficacy and Safety of XC221 in the Treatment of Influenza and Other Acute Respiratory Viral Infections

NCT03455491

Conditions: Acute Respiratory Viral Infections, Infections, Influenza, +6 more
Locations: City Clinical Hospital №9 Izhevsk, Russia

Kuban State Medical University Krasnodar, Russia

City Clinical Hospital №1 n.a. Semashko Rostov-on-Don, Russia

Ryazan State Medical University n.a. Pavlov Ryazan, Russia

View Trial Details

Completed

Influenza Virus Vaccine Plus Vitamin A and D Supplements for Prevention of Respiratory Virus Infections in Children

NCT02649192

Conditions: Healthy Participants, Infections, Influenza, Human, +5 more
Locations: St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Completed

Safety & Immunogenicity of an Alternative Immunization Schedule of GSK Bio's Pandemic Influenza Vaccine (GSK1119711A)

NCT00430521

Conditions: Infections, Influenza, Influenza Vaccines, +6 more
Locations: GSK Investigational Site Deggendorf, Bavaria, Germany

GSK Investigational Site Munich, Bavaria, Germany

GSK Investigational Site Neu-Ulm, Bavaria, Germany

GSK Investigational Site Regensburg, Bavaria, Germany

View Trial Details

Completed

The Oakland Men's Health Disparities Study

NCT03481270

Conditions: Behavior, Cardiovascular Risk Factor, Infections, +7 more
Locations: Barbershops / Fleamarkets Oakland, California, United States

View Trial Details

Orthomyxoviridae Infections

Orthomyxoviridae Infections trial results

Related conditions